Philip Maes Selected Research

Poloxamer (Poloxamer 407)

1/2021

Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip Maes Research Topics

Disease

3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 04/2005
2	Hemophilia A (Haemophilia) 08/2020 - 01/2018
1	von Willebrand Diseases (von Willebrand's Disease) 04/2022
1	Pain (Aches) 01/2021
1	Hyperbilirubinemia 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Thalassemia 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2017
1	Hypersensitivity (Allergy) 10/2017
1	Infections 10/2017
1	Leukemia 10/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2017
1	Neoplasms (Cancer) 10/2017
1	Neurologic Manifestations (Neurological Manifestations) 05/2014
1	Encephalitis (Encephalitis, Rasmussen) 05/2014
1	Anemia 04/2005

Drug/Important Bio-Agent (IBA)

1	von Willebrand FactorIBA 04/2022
1	Factor VIII (Coagulation Factor VIII)IBA 04/2022
1	Sickle HemoglobinIBA 01/2021
1	TicagrelorIBA 01/2021
1	Poloxamer (Poloxamer 407)IBA 01/2021
1	human F8 protein FDA Link 08/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018
1	Asparaginase (Elspar)FDA Link 10/2017
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	Hemoglobins (Hemoglobin)IBA 04/2005
1	Biological ProductsIBA 04/2005
1	Hydroxyurea (Hydrea)FDA LinkGeneric 04/2005

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2017
1	Combination Drug Therapy (Combination Chemotherapy) 10/2017
1	Drug Therapy (Chemotherapy) 04/2005